ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Fabry Disease Treatment Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-35P5799
Home | Market Reports | Health| Health Conditions| Genetic Disorders
Global Fabry Disease Treatment Market Insights and Forecast to 2028
BUY CHAPTERS

Global Fabry Disease Treatment Market Insights, Forecast to 2030

Code: QYRE-Auto-35P5799
Report
December 2024
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
Takeda
Amicus Therapeutics Inc
ISU ABXIS Co Ltd
JCR Pharmaceuticals Co Ltd
Protalix BioTherapeutics, Inc.
Idorsia Pharmaceuticals Ltd.
Avrobio Inc.
greenovation Biotech GmbH
Moderna Therapeutics Inc
Green Cross Pharma Pte Ltd.

Fabry Disease Treatment Market Size

The global Fabry Disease Treatment market is projected to grow from US$ 1669.1 million in 2024 to US$ 2288.3 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.4% during the forecast period.

Fabry Disease Treatment Market

Fabry Disease Treatment Market

Fabry disease is a rare X-linked lysosomal storage disorder with a deficiency of alpha galactosidase enzyme resulting in progressive organ dysfunction. This disease is caused by abnormal buildup of a specific fatty matter called globotriaosylceramide in multiple tissues of the body including eyes, skin, kidney, gastrointestinal system, brain, heart, and central nervous system.
Market Analysis and Insights: Global Fabry Disease Treatment Market
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Fabry Disease Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Fabry Disease Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Fabry Disease Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Fabry Disease Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Fabry Disease Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Fabry Disease Treatment revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Fabry Disease Treatment Market Report

Report Metric Details
Report Name Fabry Disease Treatment Market
Accounted market size in 2024 US$ 1669.1 million
Forecasted market size in 2030 US$ 2288.3 million
CAGR 5.4
Base Year 2024
Forecasted years 2025 - 2030
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sanofi S.A., Takeda, Amicus Therapeutics Inc., ISU Abxis Co Ltd., JCR Pharmaceuticals Co Ltd., Protalix Biotherapeutics Inc., Idorsia Pharmaceuticals Ltd., Avrobio Inc., Greenovation Biotech GmbH, Moderna Therapeutics Inc., Green Cross Pharma Pte Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Fabry Disease Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Fabry Disease Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Fabry Disease Treatment revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Fabry Disease Treatment Market growing?

Ans: The Fabry Disease Treatment Market witnessing a CAGR of 5.4 during the forecast period 2025-2030.

What is the Fabry Disease Treatment Market size in 2030?

Ans: The Fabry Disease Treatment Market size in 2030 will be US$ 2288.3 million.

Who are the main players in the Fabry Disease Treatment Market report?

Ans: The main players in the Fabry Disease Treatment Market are Sanofi S.A., Takeda, Amicus Therapeutics Inc., ISU Abxis Co Ltd., JCR Pharmaceuticals Co Ltd., Protalix Biotherapeutics Inc., Idorsia Pharmaceuticals Ltd., Avrobio Inc., Greenovation Biotech GmbH, Moderna Therapeutics Inc., Green Cross Pharma Pte Ltd.

What are the Application segmentation covered in the Fabry Disease Treatment Market report?

Ans: The Applications covered in the Fabry Disease Treatment Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Fabry Disease Treatment Market report?

Ans: The Types covered in the Fabry Disease Treatment Market report are Enzyme Replacement Therapy (ERT), Chaperone Treatment, Substrate Reduction Therapy (SRT), Others

Recommended Reports

Rare Disease Treatments

Organ & Metabolic Diseases

Neurological Disorders

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fabry Disease Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Enzyme Replacement Therapy (ERT)
1.2.3 Chaperone Treatment
1.2.4 Substrate Reduction Therapy (SRT)
1.2.5 Others
1.3 Market by Application
1.3.1 Global Fabry Disease Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Fabry Disease Treatment Market Perspective (2019-2030)
2.2 Global Fabry Disease Treatment Growth Trends by Region
2.2.1 Fabry Disease Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Fabry Disease Treatment Historic Market Size by Region (2019-2024)
2.2.3 Fabry Disease Treatment Forecasted Market Size by Region (2025-2030)
2.3 Fabry Disease Treatment Market Dynamics
2.3.1 Fabry Disease Treatment Industry Trends
2.3.2 Fabry Disease Treatment Market Drivers
2.3.3 Fabry Disease Treatment Market Challenges
2.3.4 Fabry Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Fabry Disease Treatment by Players
3.1.1 Global Fabry Disease Treatment Revenue by Players (2019-2024)
3.1.2 Global Fabry Disease Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Fabry Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Fabry Disease Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Fabry Disease Treatment Market Concentration Ratio
3.4.1 Global Fabry Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fabry Disease Treatment Revenue in 2023
3.5 Global Key Players of Fabry Disease Treatment Head office and Area Served
3.6 Global Key Players of Fabry Disease Treatment, Product and Application
3.7 Global Key Players of Fabry Disease Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Fabry Disease Treatment Breakdown Data by Type
4.1 Global Fabry Disease Treatment Historic Market Size by Type (2019-2024)
4.2 Global Fabry Disease Treatment Forecasted Market Size by Type (2025-2030)
5 Fabry Disease Treatment Breakdown Data by Application
5.1 Global Fabry Disease Treatment Historic Market Size by Application (2019-2024)
5.2 Global Fabry Disease Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Fabry Disease Treatment Market Size (2019-2030)
6.2 North America Fabry Disease Treatment Market Size by Type
6.2.1 North America Fabry Disease Treatment Market Size by Type (2019-2024)
6.2.2 North America Fabry Disease Treatment Market Size by Type (2025-2030)
6.2.3 North America Fabry Disease Treatment Market Share by Type (2019-2030)
6.3 North America Fabry Disease Treatment Market Size by Application
6.3.1 North America Fabry Disease Treatment Market Size by Application (2019-2024)
6.3.2 North America Fabry Disease Treatment Market Size by Application (2025-2030)
6.3.3 North America Fabry Disease Treatment Market Share by Application (2019-2030)
6.4 North America Fabry Disease Treatment Market Size by Country
6.4.1 North America Fabry Disease Treatment Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Fabry Disease Treatment Market Size by Country (2019-2024)
6.4.3 North America Fabry Disease Treatment Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Fabry Disease Treatment Market Size (2019-2030)
7.2 Europe Fabry Disease Treatment Market Size by Type
7.2.1 Europe Fabry Disease Treatment Market Size by Type (2019-2024)
7.2.2 Europe Fabry Disease Treatment Market Size by Type (2025-2030)
7.2.3 Europe Fabry Disease Treatment Market Share by Type (2019-2030)
7.3 Europe Fabry Disease Treatment Market Size by Application
7.3.1 Europe Fabry Disease Treatment Market Size by Application (2019-2024)
7.3.2 Europe Fabry Disease Treatment Market Size by Application (2025-2030)
7.3.3 Europe Fabry Disease Treatment Market Share by Application (2019-2030)
7.4 Europe Fabry Disease Treatment Market Size by Country
7.4.1 Europe Fabry Disease Treatment Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Fabry Disease Treatment Market Size by Country (2019-2024)
7.4.3 Europe Fabry Disease Treatment Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Fabry Disease Treatment Market Size (2019-2030)
8.2 China Fabry Disease Treatment Market Size by Type
8.2.1 China Fabry Disease Treatment Market Size by Type (2019-2024)
8.2.2 China Fabry Disease Treatment Market Size by Type (2025-2030)
8.2.3 China Fabry Disease Treatment Market Share by Type (2019-2030)
8.3 China Fabry Disease Treatment Market Size by Application
8.3.1 China Fabry Disease Treatment Market Size by Application (2019-2024)
8.3.2 China Fabry Disease Treatment Market Size by Application (2025-2030)
8.3.3 China Fabry Disease Treatment Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Fabry Disease Treatment Market Size (2019-2030)
9.2 Asia Fabry Disease Treatment Market Size by Type
9.2.1 Asia Fabry Disease Treatment Market Size by Type (2019-2024)
9.2.2 Asia Fabry Disease Treatment Market Size by Type (2025-2030)
9.2.3 Asia Fabry Disease Treatment Market Share by Type (2019-2030)
9.3 Asia Fabry Disease Treatment Market Size by Application
9.3.1 Asia Fabry Disease Treatment Market Size by Application (2019-2024)
9.3.2 Asia Fabry Disease Treatment Market Size by Application (2025-2030)
9.3.3 Asia Fabry Disease Treatment Market Share by Application (2019-2030)
9.4 Asia Fabry Disease Treatment Market Size by Region
9.4.1 Asia Fabry Disease Treatment Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Fabry Disease Treatment Market Size by Region (2019-2024)
9.4.3 Asia Fabry Disease Treatment Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Fabry Disease Treatment Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Fabry Disease Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Fabry Disease Treatment Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Fabry Disease Treatment Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Fabry Disease Treatment Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Fabry Disease Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Fabry Disease Treatment Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Fabry Disease Treatment Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Fabry Disease Treatment Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Fabry Disease Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Fabry Disease Treatment Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Fabry Disease Treatment Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Fabry Disease Treatment Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Sanofi S.A.
11.1.1 Sanofi S.A. Company Details
11.1.2 Sanofi S.A. Business Overview
11.1.3 Sanofi S.A. Fabry Disease Treatment Introduction
11.1.4 Sanofi S.A. Revenue in Fabry Disease Treatment Business (2019-2024)
11.1.5 Sanofi S.A. Recent Developments
11.2 Takeda
11.2.1 Takeda Company Details
11.2.2 Takeda Business Overview
11.2.3 Takeda Fabry Disease Treatment Introduction
11.2.4 Takeda Revenue in Fabry Disease Treatment Business (2019-2024)
11.2.5 Takeda Recent Developments
11.3 Amicus Therapeutics Inc.
11.3.1 Amicus Therapeutics Inc. Company Details
11.3.2 Amicus Therapeutics Inc. Business Overview
11.3.3 Amicus Therapeutics Inc. Fabry Disease Treatment Introduction
11.3.4 Amicus Therapeutics Inc. Revenue in Fabry Disease Treatment Business (2019-2024)
11.3.5 Amicus Therapeutics Inc. Recent Developments
11.4 ISU Abxis Co Ltd.
11.4.1 ISU Abxis Co Ltd. Company Details
11.4.2 ISU Abxis Co Ltd. Business Overview
11.4.3 ISU Abxis Co Ltd. Fabry Disease Treatment Introduction
11.4.4 ISU Abxis Co Ltd. Revenue in Fabry Disease Treatment Business (2019-2024)
11.4.5 ISU Abxis Co Ltd. Recent Developments
11.5 JCR Pharmaceuticals Co Ltd.
11.5.1 JCR Pharmaceuticals Co Ltd. Company Details
11.5.2 JCR Pharmaceuticals Co Ltd. Business Overview
11.5.3 JCR Pharmaceuticals Co Ltd. Fabry Disease Treatment Introduction
11.5.4 JCR Pharmaceuticals Co Ltd. Revenue in Fabry Disease Treatment Business (2019-2024)
11.5.5 JCR Pharmaceuticals Co Ltd. Recent Developments
11.6 Protalix Biotherapeutics Inc.
11.6.1 Protalix Biotherapeutics Inc. Company Details
11.6.2 Protalix Biotherapeutics Inc. Business Overview
11.6.3 Protalix Biotherapeutics Inc. Fabry Disease Treatment Introduction
11.6.4 Protalix Biotherapeutics Inc. Revenue in Fabry Disease Treatment Business (2019-2024)
11.6.5 Protalix Biotherapeutics Inc. Recent Developments
11.7 Idorsia Pharmaceuticals Ltd.
11.7.1 Idorsia Pharmaceuticals Ltd. Company Details
11.7.2 Idorsia Pharmaceuticals Ltd. Business Overview
11.7.3 Idorsia Pharmaceuticals Ltd. Fabry Disease Treatment Introduction
11.7.4 Idorsia Pharmaceuticals Ltd. Revenue in Fabry Disease Treatment Business (2019-2024)
11.7.5 Idorsia Pharmaceuticals Ltd. Recent Developments
11.8 Avrobio Inc.
11.8.1 Avrobio Inc. Company Details
11.8.2 Avrobio Inc. Business Overview
11.8.3 Avrobio Inc. Fabry Disease Treatment Introduction
11.8.4 Avrobio Inc. Revenue in Fabry Disease Treatment Business (2019-2024)
11.8.5 Avrobio Inc. Recent Developments
11.9 Greenovation Biotech GmbH
11.9.1 Greenovation Biotech GmbH Company Details
11.9.2 Greenovation Biotech GmbH Business Overview
11.9.3 Greenovation Biotech GmbH Fabry Disease Treatment Introduction
11.9.4 Greenovation Biotech GmbH Revenue in Fabry Disease Treatment Business (2019-2024)
11.9.5 Greenovation Biotech GmbH Recent Developments
11.10 Moderna Therapeutics Inc.
11.10.1 Moderna Therapeutics Inc. Company Details
11.10.2 Moderna Therapeutics Inc. Business Overview
11.10.3 Moderna Therapeutics Inc. Fabry Disease Treatment Introduction
11.10.4 Moderna Therapeutics Inc. Revenue in Fabry Disease Treatment Business (2019-2024)
11.10.5 Moderna Therapeutics Inc. Recent Developments
11.11 Green Cross Pharma Pte Ltd.
11.11.1 Green Cross Pharma Pte Ltd. Company Details
11.11.2 Green Cross Pharma Pte Ltd. Business Overview
11.11.3 Green Cross Pharma Pte Ltd. Fabry Disease Treatment Introduction
11.11.4 Green Cross Pharma Pte Ltd. Revenue in Fabry Disease Treatment Business (2019-2024)
11.11.5 Green Cross Pharma Pte Ltd. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Sanofi
Takeda
Amicus Therapeutics Inc
ISU ABXIS Co Ltd
JCR Pharmaceuticals Co Ltd
Protalix BioTherapeutics, Inc.
Idorsia Pharmaceuticals Ltd.
Avrobio Inc.
greenovation Biotech GmbH
Moderna Therapeutics Inc
Green Cross Pharma Pte Ltd.
List of Tables
    Table 1. Global Fabry Disease Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Enzyme Replacement Therapy (ERT)
    Table 3. Key Players of Chaperone Treatment
    Table 4. Key Players of Substrate Reduction Therapy (SRT)
    Table 5. Key Players of Others
    Table 6. Global Fabry Disease Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 7. Global Fabry Disease Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Fabry Disease Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Fabry Disease Treatment Market Share by Region (2019-2024)
    Table 10. Global Fabry Disease Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Fabry Disease Treatment Market Share by Region (2025-2030)
    Table 12. Fabry Disease Treatment Market Trends
    Table 13. Fabry Disease Treatment Market Drivers
    Table 14. Fabry Disease Treatment Market Challenges
    Table 15. Fabry Disease Treatment Market Restraints
    Table 16. Global Fabry Disease Treatment Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Fabry Disease Treatment Revenue Share by Players (2019-2024)
    Table 18. Global Top Fabry Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fabry Disease Treatment as of 2023)
    Table 19. Global Fabry Disease Treatment Industry Ranking 2022 VS 2023 VS 2024
    Table 20. Global 5 Largest Players Market Share by Fabry Disease Treatment Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Global Key Players of Fabry Disease Treatment, Headquarters and Area Served
    Table 22. Global Key Players of Fabry Disease Treatment, Product and Application
    Table 23. Global Key Players of Fabry Disease Treatment, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Fabry Disease Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Fabry Disease Treatment Revenue Market Share by Type (2019-2024)
    Table 27. Global Fabry Disease Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Fabry Disease Treatment Revenue Market Share by Type (2025-2030)
    Table 29. Global Fabry Disease Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Fabry Disease Treatment Revenue Share by Application (2019-2024)
    Table 31. Global Fabry Disease Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Fabry Disease Treatment Revenue Share by Application (2025-2030)
    Table 33. North America Fabry Disease Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 34. North America Fabry Disease Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 35. North America Fabry Disease Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 36. North America Fabry Disease Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 37. North America Fabry Disease Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America Fabry Disease Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America Fabry Disease Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe Fabry Disease Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 41. Europe Fabry Disease Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 42. Europe Fabry Disease Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 43. Europe Fabry Disease Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 44. Europe Fabry Disease Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Europe Fabry Disease Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Europe Fabry Disease Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 47. China Fabry Disease Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 48. China Fabry Disease Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 49. China Fabry Disease Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 50. China Fabry Disease Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 51. Asia Fabry Disease Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 52. Asia Fabry Disease Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 53. Asia Fabry Disease Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 54. Asia Fabry Disease Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Fabry Disease Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 56. Asia Fabry Disease Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 57. Asia Fabry Disease Treatment Market Size by Region (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Fabry Disease Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Fabry Disease Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Fabry Disease Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Fabry Disease Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Fabry Disease Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 63. Middle East, Africa, and Latin America Fabry Disease Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Fabry Disease Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 65. Sanofi S.A. Company Details
    Table 66. Sanofi S.A. Business Overview
    Table 67. Sanofi S.A. Fabry Disease Treatment Product
    Table 68. Sanofi S.A. Revenue in Fabry Disease Treatment Business (2019-2024) & (US$ Million)
    Table 69. Sanofi S.A. Recent Developments
    Table 70. Takeda Company Details
    Table 71. Takeda Business Overview
    Table 72. Takeda Fabry Disease Treatment Product
    Table 73. Takeda Revenue in Fabry Disease Treatment Business (2019-2024) & (US$ Million)
    Table 74. Takeda Recent Developments
    Table 75. Amicus Therapeutics Inc. Company Details
    Table 76. Amicus Therapeutics Inc. Business Overview
    Table 77. Amicus Therapeutics Inc. Fabry Disease Treatment Product
    Table 78. Amicus Therapeutics Inc. Revenue in Fabry Disease Treatment Business (2019-2024) & (US$ Million)
    Table 79. Amicus Therapeutics Inc. Recent Developments
    Table 80. ISU Abxis Co Ltd. Company Details
    Table 81. ISU Abxis Co Ltd. Business Overview
    Table 82. ISU Abxis Co Ltd. Fabry Disease Treatment Product
    Table 83. ISU Abxis Co Ltd. Revenue in Fabry Disease Treatment Business (2019-2024) & (US$ Million)
    Table 84. ISU Abxis Co Ltd. Recent Developments
    Table 85. JCR Pharmaceuticals Co Ltd. Company Details
    Table 86. JCR Pharmaceuticals Co Ltd. Business Overview
    Table 87. JCR Pharmaceuticals Co Ltd. Fabry Disease Treatment Product
    Table 88. JCR Pharmaceuticals Co Ltd. Revenue in Fabry Disease Treatment Business (2019-2024) & (US$ Million)
    Table 89. JCR Pharmaceuticals Co Ltd. Recent Developments
    Table 90. Protalix Biotherapeutics Inc. Company Details
    Table 91. Protalix Biotherapeutics Inc. Business Overview
    Table 92. Protalix Biotherapeutics Inc. Fabry Disease Treatment Product
    Table 93. Protalix Biotherapeutics Inc. Revenue in Fabry Disease Treatment Business (2019-2024) & (US$ Million)
    Table 94. Protalix Biotherapeutics Inc. Recent Developments
    Table 95. Idorsia Pharmaceuticals Ltd. Company Details
    Table 96. Idorsia Pharmaceuticals Ltd. Business Overview
    Table 97. Idorsia Pharmaceuticals Ltd. Fabry Disease Treatment Product
    Table 98. Idorsia Pharmaceuticals Ltd. Revenue in Fabry Disease Treatment Business (2019-2024) & (US$ Million)
    Table 99. Idorsia Pharmaceuticals Ltd. Recent Developments
    Table 100. Avrobio Inc. Company Details
    Table 101. Avrobio Inc. Business Overview
    Table 102. Avrobio Inc. Fabry Disease Treatment Product
    Table 103. Avrobio Inc. Revenue in Fabry Disease Treatment Business (2019-2024) & (US$ Million)
    Table 104. Avrobio Inc. Recent Developments
    Table 105. Greenovation Biotech GmbH Company Details
    Table 106. Greenovation Biotech GmbH Business Overview
    Table 107. Greenovation Biotech GmbH Fabry Disease Treatment Product
    Table 108. Greenovation Biotech GmbH Revenue in Fabry Disease Treatment Business (2019-2024) & (US$ Million)
    Table 109. Greenovation Biotech GmbH Recent Developments
    Table 110. Moderna Therapeutics Inc. Company Details
    Table 111. Moderna Therapeutics Inc. Business Overview
    Table 112. Moderna Therapeutics Inc. Fabry Disease Treatment Product
    Table 113. Moderna Therapeutics Inc. Revenue in Fabry Disease Treatment Business (2019-2024) & (US$ Million)
    Table 114. Moderna Therapeutics Inc. Recent Developments
    Table 115. Green Cross Pharma Pte Ltd. Company Details
    Table 116. Green Cross Pharma Pte Ltd. Business Overview
    Table 117. Green Cross Pharma Pte Ltd. Fabry Disease Treatment Product
    Table 118. Green Cross Pharma Pte Ltd. Revenue in Fabry Disease Treatment Business (2019-2024) & (US$ Million)
    Table 119. Green Cross Pharma Pte Ltd. Recent Developments
    Table 120. Research Programs/Design for This Report
    Table 121. Key Data Information from Secondary Sources
    Table 122. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Fabry Disease Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Fabry Disease Treatment Market Share by Type: 2023 VS 2030
    Figure 3. Enzyme Replacement Therapy (ERT) Features
    Figure 4. Chaperone Treatment Features
    Figure 5. Substrate Reduction Therapy (SRT) Features
    Figure 6. Others Features
    Figure 7. Global Fabry Disease Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Fabry Disease Treatment Market Share by Application: 2023 VS 2030
    Figure 9. Hospital Case Studies
    Figure 10. Clinic Case Studies
    Figure 11. Others Case Studies
    Figure 12. Fabry Disease Treatment Report Years Considered
    Figure 13. Global Fabry Disease Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Fabry Disease Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Fabry Disease Treatment Market Share by Region: 2023 VS 2030
    Figure 16. Global Fabry Disease Treatment Market Share by Players in 2023
    Figure 17. Global Top Fabry Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fabry Disease Treatment as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Fabry Disease Treatment Revenue in 2023
    Figure 19. North America Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Fabry Disease Treatment Market Share by Type (2019-2030)
    Figure 21. North America Fabry Disease Treatment Market Share by Application (2019-2030)
    Figure 22. North America Fabry Disease Treatment Market Share by Country (2019-2030)
    Figure 23. United States Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Fabry Disease Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Fabry Disease Treatment Market Share by Type (2019-2030)
    Figure 27. Europe Fabry Disease Treatment Market Share by Application (2019-2030)
    Figure 28. Europe Fabry Disease Treatment Market Share by Country (2019-2030)
    Figure 29. Germany Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Fabry Disease Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Fabry Disease Treatment Market Share by Type (2019-2030)
    Figure 37. China Fabry Disease Treatment Market Share by Application (2019-2030)
    Figure 38. Asia Fabry Disease Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Fabry Disease Treatment Market Share by Type (2019-2030)
    Figure 40. Asia Fabry Disease Treatment Market Share by Application (2019-2030)
    Figure 41. Asia Fabry Disease Treatment Market Share by Region (2019-2030)
    Figure 42. Japan Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Fabry Disease Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Fabry Disease Treatment Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Fabry Disease Treatment Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Fabry Disease Treatment Market Share by Country (2019-2030)
    Figure 52. Brazil Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Sanofi S.A. Revenue Growth Rate in Fabry Disease Treatment Business (2019-2024)
    Figure 59. Takeda Revenue Growth Rate in Fabry Disease Treatment Business (2019-2024)
    Figure 60. Amicus Therapeutics Inc. Revenue Growth Rate in Fabry Disease Treatment Business (2019-2024)
    Figure 61. ISU Abxis Co Ltd. Revenue Growth Rate in Fabry Disease Treatment Business (2019-2024)
    Figure 62. JCR Pharmaceuticals Co Ltd. Revenue Growth Rate in Fabry Disease Treatment Business (2019-2024)
    Figure 63. Protalix Biotherapeutics Inc. Revenue Growth Rate in Fabry Disease Treatment Business (2019-2024)
    Figure 64. Idorsia Pharmaceuticals Ltd. Revenue Growth Rate in Fabry Disease Treatment Business (2019-2024)
    Figure 65. Avrobio Inc. Revenue Growth Rate in Fabry Disease Treatment Business (2019-2024)
    Figure 66. Greenovation Biotech GmbH Revenue Growth Rate in Fabry Disease Treatment Business (2019-2024)
    Figure 67. Moderna Therapeutics Inc. Revenue Growth Rate in Fabry Disease Treatment Business (2019-2024)
    Figure 68. Green Cross Pharma Pte Ltd. Revenue Growth Rate in Fabry Disease Treatment Business (2019-2024)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Lysosomal Storage Disease Treatment Market Research Report 2024
Global Gaucher Disease GD Drugs Market Insights Forecast to 2030
Global Sphingolipidoses Treatment Market Research Report 2025
Gaucher Disease Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gaucher Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cystic Fibrosis Treatment Market Insights Forecast to 2030
Global Albinism Drug Market Insights Forecast to 2030
Global Lysosomal Storage Disorder Drugs Market Research Report 2024
GM1 Gangliosidosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Lysosomal Storage Diseases Market Research Report 2024
Global Optic Nerve Disorders Treatment Market Insights Forecast to 2030
Adrenoleukodystrophy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Neurodegenerative Disease Market Insights Forecast to 2030
Global Multiple Sclerosis Drugs Treatment Market Insights Forecast to 2030
Carasil Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Fabrazyme agalsidase beta Market Insights Forecast to 2030
Gaucher s Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Alzheimer s Disease Therapeutics and Diagnostics Market Insights Forecast to 2030
Global Hyperpigmentation Disorder Treatment Market Insights Forecast to 2030
Alpha Mannosidosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Lysosomal Storage Disease Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17R1241
Mon Sep 15 00:00:00 UTC 2025

Add to Cart

Global Klippel Trenaunay Syndrome Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20L1035
Mon Sep 15 00:00:00 UTC 2025

Add to Cart

Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24R5886
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Lysosomal Storage Diseases Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34Q5936
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions